Skip to main content
. 2021 Apr 19;2021:9969010. doi: 10.1155/2021/9969010

Table 2.

Number of MS patients improved after SCS according to the evaluated function.

Function Improvement (yes/no) p
All patients
Motor disorders 193/153
Urinary dysfunction 90/44 p = 0.0144
Neuropathic pain 28/6 p = 0.0030

Patients submitted to the trial and then implanted
Motor disorders 158/121
Urinary dysfunction 40/17 p = 0.038
Neuropathic pain 15/4 p = 0.044

Patients with de novo implantation
Motor disorders 35/32
Urinary dysfunction 50/27 n.s
Neuropathic pain 13/2 p = 0.0126